Has Gary Yen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,415 in general payments to Gary Yen, MD across 14 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Gary Yen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Gary Yen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Gary Yen, MD

Pain Medicine · Marlboro, NJNPI 1356383566

Payments from drug & device makers

$2,415in general payments, 2019–2025

Across 14 payments — averaging $172.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Angiodynamics, Inc.$2K
SPR Therapeutics, Inc$153
Amgen$124
Globus Medical$92
Johnson & Johnson$53
Merz North America, Inc.$44
plus $51 from 2 others

What the payments were for

Travel & lodging$1,50262%
Food & beverage$91438%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Angiodynamics, Inc.	2	$1,899
SPR Therapeutics, Inc	2	$153
Amgen	3	$124
Globus Medical	1	$92
Johnson & Johnson	2	$53
Merz North America, Inc.	1	$44
AbbVie(2 entities)	2	$30
Orthogenrx Inc.	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PENNSAID$101

How this compares

$2,415 in reported general payments places this provider in the 65th percentile of 256 pain medicine providers in New Jersey.

See all pain medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024

$469,301

Medicare patients

404

Services billed

7,139

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	28	$1,604
Oxycodone Hcl	27	$659
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	28	$548
Gabapentin	35	$429
Pregabalin	18	$273
Tramadol Hcl	41	$150
Cyclobenzaprine Hcl	13	$106
Alprazolam	16	$88

Paid to pharmacies, not to this prescriber.

Other pain medicine in Marlboro

Sean LiShrewsbury$2.2M
Matthias WiederholzLawrenceville$866K
Todd StitikNewark$370K
Peter StaatsShrewsbury$362K
Warren GraceEdison$158K
Caitlin InnerfieldHaddonfield$97K
Rajat SekharWhiting$84K
Anson MoiseEnglewood$78K
Samyadev DattaHackensack$65K
Pavli DemianSomerset$65K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →